BridgeMD
New treatment option for Obsessive-Compulsive Disorder
Official title Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.
ClinicalTrials.gov ID: NCT06346301
What this study is testing
- What it's testing
- The goal of this multiple baseline case series study is to test the effect of imagery rescripting (ImRs) in Obsessive Compulsive Disorder (OCD) and Body Dysmorphic Disorder (BDD). Primary objective :The course of schema or core beliefs and change in OCD and BDD.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Meet the criteria for OCD or BDD, a primary diagnosis according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
- Are aged 18 and beyond
- Dutch literacy
- Cut-off Y-BOCS of 20
- No change in medication. Stable dose at least 6 weeks prior to study.
You likely can't join if
- Current (hypo)mania
- Active suicidal plans
- Current psychosis (excluding delusional symptoms related to disorder)
- Alcohol or drugs abuse as diagnosed by Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
- Electroconvulsive therapy in last 6 months
- Neurological disorder or Intelligence Quotient \< 80
The study team makes the final eligibility decision.
Where it's taking place
- Amsterdam-Zuidoost, North Holland, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amsterdam-Zuidoost, North Holland, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.